Search results
Earnings call: Myriad Genetics posts strong Q1 with revenue growth By Investing.com
Investing.com· 2 hours agoMyriad Genetics (NASDAQ:MYGN), a leading player in genetic testing and precision medicine, has...
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
Zacks via Yahoo Finance· 8 hours agoMyriad Genetics (MYGN) first-quarter average revenue per test across its product portfolio benefited...
SOPHiA GENETICS First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 12 hours agoSOPHiA GENETICS (NASDAQ:SOPH) First Quarter 2024 Results Key Financial Results Revenue: US$15.8m (up...
UBS analysts initates a Neutral rating for Fulgent Genetics Inc
Knox Daily· 17 hours agoFulgent Genetics Inc’s recently made public that its President and COO Xie Jian unloaded Company’s shares for reported $0.58 million on Dec 11 ’23. In the deal valued at $26.52 ...
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 hours agoArcus Biosciences (RCUS) delivered earnings and revenue surprises of 94.85% and 454.49%,...
Why Adaptive Biotechnologies Topped the Market Today
Motley Fool via Yahoo Finance· 1 hour agoAdaptive Biotechnologies (NASDAQ: ADPT), a company that, in its own words, "aims to translate the genetics of the adaptive immune system into clinical...
Genetics studies have a diversity problem that researchers struggle to fix
Boston Herald· 1 day agoThe goal is to better understand how genes affect health risks such as cancer and heart disease....
Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a Bet
Zacks via Yahoo Finance· 1 day agoThe average of price targets set by Wall Street analysts indicates a potential upside of 65% in...
Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...
GuruFocus.com via Yahoo Finance· 16 hours agoExplore key insights from Myriad Genetics' Q1 2024 earnings, featuring significant revenue increases and strategic initiatives aimed at enhancing market position.
Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
GuruFocus.com via Yahoo Finance· 1 day agoOperational Developments: Announced the reorganization of European operations and the sale of the...